Literature DB >> 20103622

Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach.

Jenny Mattison1, Jaap Kool, Anthony G Uren, Jeroen de Ridder, Lodewyk Wessels, Jos Jonkers, Graham R Bignell, Adam Butler, Alistair G Rust, Markus Brosch, Catherine H Wilson, Louise van der Weyden, David A Largaespada, Michael R Stratton, P Andy Futreal, Maarten van Lohuizen, Anton Berns, Lara S Collier, Tim Hubbard, David J Adams.   

Abstract

Comparative genomic hybridization (CGH) can reveal important disease genes but the large regions identified could sometimes contain hundreds of genes. Here we combine high-resolution CGH analysis of 598 human cancer cell lines with insertion sites isolated from 1,005 mouse tumors induced with the murine leukemia virus (MuLV). This cross-species oncogenomic analysis revealed candidate tumor suppressor genes and oncogenes mutated in both human and mouse tumors, making them strong candidates for novel cancer genes. A significant number of these genes contained binding sites for the stem cell transcription factors Oct4 and Nanog. Notably, mice carrying tumors with insertions in or near stem cell module genes, which are thought to participate in cell self-renewal, died significantly faster than mice without these insertions. A comparison of the profile we identified to that induced with the Sleeping Beauty (SB) transposon system revealed significant differences in the profile of recurrently mutated genes. Collectively, this work provides a rich catalogue of new candidate cancer genes for functional analysis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20103622      PMCID: PMC2880710          DOI: 10.1158/0008-5472.CAN-09-1737

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

1.  Lack of Bcl11b tumor suppressor results in vulnerability to DNA replication stress and damages.

Authors:  K Kamimura; Y Mishima; M Obata; T Endo; Y Aoyagi; R Kominami
Journal:  Oncogene       Date:  2007-03-19       Impact factor: 9.867

2.  The Catalogue of Somatic Mutations in Cancer (COSMIC).

Authors:  S A Forbes; G Bhamra; S Bamford; E Dawson; C Kok; J Clements; A Menzies; J W Teague; P A Futreal; M R Stratton
Journal:  Curr Protoc Hum Genet       Date:  2008-04

3.  Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4.

Authors:  J Nichols; B Zevnik; K Anastassiadis; H Niwa; D Klewe-Nebenius; I Chambers; H Schöler; A Smith
Journal:  Cell       Date:  1998-10-30       Impact factor: 41.582

4.  Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse.

Authors:  Lara S Collier; Corey M Carlson; Shruthi Ravimohan; Adam J Dupuy; David A Largaespada
Journal:  Nature       Date:  2005-07-14       Impact factor: 49.962

5.  The consensus coding sequences of human breast and colorectal cancers.

Authors:  Tobias Sjöblom; Siân Jones; Laura D Wood; D Williams Parsons; Jimmy Lin; Thomas D Barber; Diana Mandelker; Rebecca J Leary; Janine Ptak; Natalie Silliman; Steve Szabo; Phillip Buckhaults; Christopher Farrell; Paul Meeh; Sanford D Markowitz; Joseph Willis; Dawn Dawson; James K V Willson; Adi F Gazdar; James Hartigan; Leo Wu; Changsheng Liu; Giovanni Parmigiani; Ben Ho Park; Kurtis E Bachman; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu
Journal:  Science       Date:  2006-09-07       Impact factor: 47.728

6.  Selection for c-myc integration sites in polyclonal T-cell lymphomas.

Authors:  Dana R Broussard; Jennifer A Mertz; M Lozano; Jaquelin P Dudley
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.

Authors:  Ittai Ben-Porath; Matthew W Thomson; Vincent J Carey; Ruping Ge; George W Bell; Aviv Regev; Robert A Weinberg
Journal:  Nat Genet       Date:  2008-05       Impact factor: 38.330

8.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays.

Authors:  D Pinkel; R Segraves; D Sudar; S Clark; I Poole; D Kowbel; C Collins; W L Kuo; C Chen; Y Zhai; S H Dairkee; B M Ljung; J W Gray; D G Albertson
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

Review 9.  Chromosome fragile sites.

Authors:  Sandra G Durkin; Thomas W Glover
Journal:  Annu Rev Genet       Date:  2007       Impact factor: 16.830

10.  Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

Authors:  Lars Zender; Mona S Spector; Wen Xue; Peer Flemming; Carlos Cordon-Cardo; John Silke; Sheung-Tat Fan; John M Luk; Michael Wigler; Gregory J Hannon; David Mu; Robert Lucito; Scott Powers; Scott W Lowe
Journal:  Cell       Date:  2006-06-30       Impact factor: 41.582

View more
  24 in total

1.  Oct1 is a switchable, bipotential stabilizer of repressed and inducible transcriptional states.

Authors:  Arvind Shakya; Jinsuk Kang; Jeffrey Chumley; Matthew A Williams; Dean Tantin
Journal:  J Biol Chem       Date:  2010-11-04       Impact factor: 5.157

Review 2.  Transposon-based screens for cancer gene discovery in mouse models.

Authors:  Adam J Dupuy
Journal:  Semin Cancer Biol       Date:  2010-05-15       Impact factor: 15.707

3.  Prototypic chromatin insulator cHS4 protects retroviral transgene from silencing in Schistosoma mansoni.

Authors:  Sutas Suttiprapa; Gabriel Rinaldi; Paul J Brindley
Journal:  Transgenic Res       Date:  2011-09-15       Impact factor: 2.788

Review 4.  From cancer genomes to oncogenic drivers, tumour dependencies and therapeutic targets.

Authors:  Cheryl Eifert; R Scott Powers
Journal:  Nat Rev Cancer       Date:  2012-08       Impact factor: 60.716

5.  Challenges in identifying candidate amplification targets in human cancers: chromosome 8q21 as a case study.

Authors:  Jennifer A Byrne; Yuyan Chen; Nancy Martin La Rotta; Gregory B Peters
Journal:  Genes Cancer       Date:  2012-02

6.  Cell of origin strongly influences genetic selection in a mouse model of T-ALL.

Authors:  Katherine E Berquam-Vrieze; Kishore Nannapaneni; Benjamin T Brett; Linda Holmfeldt; Jing Ma; Oksana Zagorodna; Nancy A Jenkins; Neal G Copeland; David K Meyerholz; C Michael Knudson; Charles G Mullighan; Todd E Scheetz; Adam J Dupuy
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

Review 7.  Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?

Authors:  Jennifer A Byrne; Sarah Frost; Yuyan Chen; Robert K Bright
Journal:  Tumour Biol       Date:  2014-05-06

8.  Stemness-related transcriptional factors and homing gene expression profiles in hepatic differentiation and cancer.

Authors:  Eman A Toraih; Manal S Fawzy; Abdullah I El-Falouji; Elham O Hamed; Nader A Nemr; Mohammad H Hussein; Noha M Abd El Fadeal
Journal:  Mol Med       Date:  2016-09-12       Impact factor: 6.354

9.  Transcription factor Oct1 is a somatic and cancer stem cell determinant.

Authors:  Jessica Maddox; Arvind Shakya; Samuel South; Dawne Shelton; Jared N Andersen; Stephanie Chidester; Jinsuk Kang; Keith M Gligorich; David A Jones; Gerald J Spangrude; Bryan E Welm; Dean Tantin
Journal:  PLoS Genet       Date:  2012-11-08       Impact factor: 5.917

10.  Computational identification of insertional mutagenesis targets for cancer gene discovery.

Authors:  Johann de Jong; Jeroen de Ridder; Louise van der Weyden; Ning Sun; Miranda van Uitert; Anton Berns; Maarten van Lohuizen; Jos Jonkers; David J Adams; Lodewyk F A Wessels
Journal:  Nucleic Acids Res       Date:  2011-06-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.